| Date |
Title |
| September 19, 2024, 9:37 pm |
DeepDrive's €30 Million Boost: A Game Changer for Electric Motors |
| September 19, 2024, 9:37 pm |
Gestalt Tech: A New Dawn for Lenders with $5.9 Million Seed Funding |
| September 19, 2024, 9:37 pm |
Nomic Bio's $42 Million Leap: A New Era in Protein Profiling |
| September 19, 2024, 9:37 pm |
Vahan.ai: Pioneering Blue-Collar Recruitment with a $10 Million Boost |
| September 19, 2024, 9:37 pm |
DailyObjects Secures $10 Million to Fuel Growth and Innovation |
| September 19, 2024, 9:37 pm |
Lightium's $7 Million Seed Round: A Game Changer for Data Centers |
| September 19, 2024, 9:37 pm |
Reform RX: Revolutionizing Pilates with $5.1M in Fresh Funding |
| September 19, 2024, 9:37 pm |
NowPurchase Secures $6 Million to Transform Metal Manufacturing |
| September 19, 2024, 3:45 pm |
Saramonic's WiTalk9 Series: A Game Changer in Wireless Communication |
| September 19, 2024, 3:38 pm |
The AI Revolution: Expanding Horizons in Europe and Beyond |
| September 19, 2024, 3:38 pm |
The Intersection of Fashion and Technology: Centric Software's AI Revolution |
| September 19, 2024, 10:03 am |
The Long Walk: A Journey Through Endurance and Nature |
| September 19, 2024, 10:01 am |
The Pulse of Innovation: A Dive into Recent Funding Trends in Southeast Asia |
| September 19, 2024, 4:28 am |
Dandelion Health's AI Revolution: A New Dawn for Cardiovascular Disease Prevention |
| September 19, 2024, 4:26 am |
Fidelity Japan Trust's Recent Share Buybacks: A Strategic Move in Turbulent Waters |
| September 19, 2024, 4:25 am |
Innovent Biologics: Pioneering New Frontiers in Cancer Treatment |
| September 19, 2024, 4:22 am |
Telix and Cardinal Health: A New Era in Kidney Cancer Diagnostics |
| September 19, 2024, 4:22 am |
Promising Advances in Cancer and Heart Failure Treatments: A Look at Harbour BioMed and AnaCardio |
| September 19, 2024, 4:20 am |
Navigating the Cyber Frontier: Intel 471's Award-Winning Approach to Cyber Threat Intelligence |
| September 19, 2024, 4:18 am |
Brain+ A/S: Pioneering Cognitive Care in the UK Market |